News

Breaking News | Industry News

Stevanato Group, Catalent Partner to Expedite Equipment Installation

Stevanato’s high-speed visual inspection machines will support biologic and vaccine programs at Catalent manufacturing sites in U.S. and Italy.

Contract Pharma Staff 10.27.20

Biologics, Proteins, Vaccines | Breaking News | Drug Development | Drug Discovery | Industry News

ImmunOs Uses ProBioGen’s Pathway Modulator Technology

DirectedLuck transposase technology will be used to increase protein yield of selected candidates in their pipeline of complex recombinant proteins.

Contract Pharma Staff 10.27.20

Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances

REGENXBIO Achieves $80M Novartis Milestone

Zolgensma, which leverages REGENXBIO's NAV AAV9 vector, reaches $1 billion in sales.

Contract Pharma Staff 10.27.20

3P Biopharmaceuticals and SpyBiotech Enter Vaccine Contract Manufacturing Agreement

Looking towards completing production in 2021.

Contract Pharma Staff 10.26.20

Breaking News | Collaborations & Alliances | Facilities | Industry News

Construction Starts on the Medicines Manufacturing Innovation Center

Will offer next-gen solutions in small molecule and pharmaceutical manufacturing.

Contract Pharma Staff 10.26.20

Breaking News | Facilities | Industry News | QA/QC

Wuxi Griffin Completes Investment in New QC Lab and Storage Facility

Offers fully equipped microbiology and analytical testing lab for bulk and final product testing.

Contract Pharma Staff 10.26.20

Financial Reports

Financial Report: Biogen

Revenues down 6% in the quarter to $3.4 billion.

Contract Pharma Staff 10.26.20

Breaking News | Industry News | Promotions & Moves

CDMO Frontida Strengthens Quality Operations

Names Steven Roese as the new vice president of quality.

Contract Pharma Staff 10.26.20

Breaking News | Drug Development | Trials & Filings

Gilead’s Remdesivir Wins FDA Approval to Treat COVID-19

Veklury is now the first and only approved COVID-19 treatment in the U.S.

Contract Pharma Staff 10.23.20

Breaking News | Industry News

LaunchWorks CDMO Approved to Provide Viral Transport Media

Added to FDA list of approved vendors for validating and distributing VTM, in accordance with COVID-19 EUA Transport Media Policy.

Contract Pharma Staff 10.23.20

Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances

ABEC Delivers Process Systems to Ology Bio

Supports production of critical vaccines and therapeutics for COVID-19.

Contract Pharma Staff 10.22.20

Breaking News | Industry News | Packaging & Tracking

LaunchWorks CDMO Approved for Viral Transport Media

Added to FDA list of approved vendors for validating and distributing VTM in accordance with COVID-19 EUA Transport Media Policy.

10.22.20

Biologics, Proteins, Vaccines | Breaking News | Clinical Trials | Industry News

Moderna Completes Enrollment in Phase III COVID-19 Vax Study

COVE study designed in collaboration with the FDA and NIH to evaluate Americans at the highest risk of severe COVID-19 disease in 30,000 participants.

Contract Pharma Staff 10.22.20

Breaking News | Collaborations & Alliances

Elsevier, Novartis Collaborate on Risk Assessment Prediction Tool

To develop a safety margin risk assessment prediction tool, largely using PharmaPendium data.

Contract Pharma Staff 10.22.20

Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances

Kamada Signs Supply Agreement with Israeli Health Authorities

Will provide investigational Covid-19 plasma-derived Immunoglobulin.

Contract Pharma Staff 10.22.20

Breaking News | cGMP Manufacture | Drug Development | Industry News

Roche, Atea Pharma to Develop Potential Oral COVID-19 Treatment

To develop, manufacture and distribute AT-527, Atea’s investigational oral direct-acting antiviral being studied to treat COVID-19.

Contract Pharma Staff 10.22.20

Breaking News | cGMP Manufacture | Clinical Trial Materials | Industry News | Scale-up/Technology Transfer

Catalent, BrainStorm Enter ALS Drug Manufacturing Pact

Catalent will undertake the transfer of the manufacturing process to, and provide future cGMP clinical supply of NurOwn from its Houston facility.

Contract Pharma Staff 10.22.20

ProBioGen, Heidelberg Pharma Ink ATAC Agreement

ProBioGen is conducting cell line development, process development and GMP manufacturing of the mAb intermediates of Heidelberg’s ATAC molecules for cancer.

10.22.20

Breaking News | cGMP Manufacture | Industry News

Lonza Expands Capsule Mfg. Capacity

$93 million investment to expand production capacity of capsules in CHI's Capsugel portfolio by 30 billion capsules annually, or 15%.

10.22.20

Breaking News | Industry News | Packaging & Tracking | Serialization

TraceLink Launches Serialized Product Intelligence Solution

Allows companies to proactively monitor their serialized operations and gain actionable insights to avoid costly delays and ensure product availability.

Contract Pharma Staff 10.21.20